Nitya Nair
Roche (Switzerland)(CH)Thomas Jefferson University(US)Sree Chitra Thirunal Institute for Medical Sciences and Technology(IN)Government of Kerala(IN)
Publications by Year
Research Areas
interferon and immune responses, Cytokine Signaling Pathways and Interactions, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, Cancer Research and Treatments
Most-Cited Works
- → Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas(2021)338 cited
- → Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization(2013)299 cited
- → Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)(2019)255 cited
- → Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study(2022)212 cited
- → Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.(2019)187 cited